nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP4A11—vagina—uterine fibroid	0.0285	0.0629	CbGeAlD
Lansoprazole—CYP2C18—uterine cervix—uterine fibroid	0.0278	0.0615	CbGeAlD
Lansoprazole—CYP1B1—Endogenous sterols—CYP17A1—uterine fibroid	0.026	0.0474	CbGpPWpGaD
Lansoprazole—ATP4A—female reproductive system—uterine fibroid	0.0254	0.0561	CbGeAlD
Lansoprazole—CYP2C18—mammalian vulva—uterine fibroid	0.0243	0.0538	CbGeAlD
Lansoprazole—MAPT—LKB1 signaling events—ESR1—uterine fibroid	0.0223	0.0407	CbGpPWpGaD
Lansoprazole—CYP1B1—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.0217	0.0395	CbGpPWpGaD
Lansoprazole—CYP2C18—vagina—uterine fibroid	0.0189	0.0417	CbGeAlD
Lansoprazole—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0187	0.0342	CbGpPWpGaD
Lansoprazole—CYP4A11—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.0185	0.0337	CbGpPWpGaD
Lansoprazole—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0164	0.0299	CbGpPWpGaD
Lansoprazole—CYP2C18—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.0161	0.0295	CbGpPWpGaD
Lansoprazole—CYP4A11—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.0152	0.0277	CbGpPWpGaD
Lansoprazole—CYP1A2—nipple—uterine fibroid	0.0145	0.032	CbGeAlD
Lansoprazole—CYP1A1—nipple—uterine fibroid	0.0143	0.0316	CbGeAlD
Lansoprazole—CYP4A11—PPARA activates gene expression—MED12—uterine fibroid	0.0138	0.0251	CbGpPWpGaD
Lansoprazole—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—uterine fibroid	0.0135	0.0246	CbGpPWpGaD
Lansoprazole—CYP1A1—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.0133	0.0244	CbGpPWpGaD
Lansoprazole—CYP2C18—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.0133	0.0242	CbGpPWpGaD
Lansoprazole—CYP1B1—smooth muscle tissue—uterine fibroid	0.0131	0.029	CbGeAlD
Lansoprazole—ABCG2—myometrium—uterine fibroid	0.0129	0.0285	CbGeAlD
Lansoprazole—CYP1B1—decidua—uterine fibroid	0.0128	0.0284	CbGeAlD
Lansoprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0121	0.022	CbGpPWpGaD
Lansoprazole—CYP1B1—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.0119	0.0217	CbGpPWpGaD
Lansoprazole—CYP1B1—uterus—uterine fibroid	0.0112	0.0248	CbGeAlD
Lansoprazole—CYP2C18—FOXA1 transcription factor network—ESR1—uterine fibroid	0.0111	0.0202	CbGpPWpGaD
Lansoprazole—CYP1B1—female reproductive system—uterine fibroid	0.0101	0.0223	CbGeAlD
Lansoprazole—ABCG2—uterine cervix—uterine fibroid	0.01	0.0222	CbGeAlD
Lansoprazole—CYP1B1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00977	0.0178	CbGpPWpGaD
Lansoprazole—ABCG2—decidua—uterine fibroid	0.00956	0.0211	CbGeAlD
Lansoprazole—CYP1A1—uterine cervix—uterine fibroid	0.00953	0.0211	CbGeAlD
Lansoprazole—CYP2C8—endometrium—uterine fibroid	0.00934	0.0206	CbGeAlD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—uterine fibroid	0.00928	0.0169	CbGpPWpGaD
Lansoprazole—ABCG2—urethra—uterine fibroid	0.00923	0.0204	CbGeAlD
Lansoprazole—CYP1B1—female gonad—uterine fibroid	0.00919	0.0203	CbGeAlD
Lansoprazole—ABCG2—endometrium—uterine fibroid	0.00908	0.0201	CbGeAlD
Lansoprazole—ABCG2—mammalian vulva—uterine fibroid	0.00878	0.0194	CbGeAlD
Lansoprazole—CYP1A1—urethra—uterine fibroid	0.00876	0.0194	CbGeAlD
Lansoprazole—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.00851	0.0155	CbGpPWpGaD
Lansoprazole—ABCG2—uterus—uterine fibroid	0.00837	0.0185	CbGeAlD
Lansoprazole—CYP1A1—mammalian vulva—uterine fibroid	0.00834	0.0184	CbGeAlD
Lansoprazole—CYP4A11—Biological oxidations—CYP17A1—uterine fibroid	0.00806	0.0147	CbGpPWpGaD
Lansoprazole—CYP2C19—vagina—uterine fibroid	0.00802	0.0177	CbGeAlD
Lansoprazole—CYP1A1—cardiac atrium—uterine fibroid	0.00798	0.0177	CbGeAlD
Lansoprazole—CYP1A1—uterus—uterine fibroid	0.00794	0.0176	CbGeAlD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.00788	0.0144	CbGpPWpGaD
Lansoprazole—CYP2C8—female reproductive system—uterine fibroid	0.00774	0.0171	CbGeAlD
Lansoprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00743	0.0136	CbGpPWpGaD
Lansoprazole—CYP1A1—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00733	0.0134	CbGpPWpGaD
Lansoprazole—CYP1A1—female reproductive system—uterine fibroid	0.00714	0.0158	CbGeAlD
Lansoprazole—CYP2C18—Biological oxidations—CYP17A1—uterine fibroid	0.00704	0.0129	CbGpPWpGaD
Lansoprazole—CYP2C8—vagina—uterine fibroid	0.007	0.0155	CbGeAlD
Lansoprazole—CYP2C18—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00695	0.0127	CbGpPWpGaD
Lansoprazole—CYP2C9—female reproductive system—uterine fibroid	0.00687	0.0152	CbGeAlD
Lansoprazole—ABCG2—female gonad—uterine fibroid	0.00684	0.0151	CbGeAlD
Lansoprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00681	0.0124	CbGpPWpGaD
Lansoprazole—ABCG2—vagina—uterine fibroid	0.0068	0.015	CbGeAlD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00677	0.0124	CbGpPWpGaD
Lansoprazole—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00672	0.0123	CbGpPWpGaD
Lansoprazole—CYP1A1—female gonad—uterine fibroid	0.0065	0.0144	CbGeAlD
Lansoprazole—CYP1A1—vagina—uterine fibroid	0.00646	0.0143	CbGeAlD
Lansoprazole—ABCB1—myometrium—uterine fibroid	0.00636	0.0141	CbGeAlD
Lansoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00608	0.0111	CbGpPWpGaD
Lansoprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00602	0.011	CbGpPWpGaD
Lansoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.006	0.0109	CbGpPWpGaD
Lansoprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00559	0.0102	CbGpPWpGaD
Lansoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00554	0.0101	CbGpPWpGaD
Lansoprazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00552	0.0101	CbGpPWpGaD
Lansoprazole—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00552	0.0101	CbGpPWpGaD
Lansoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00547	0.00998	CbGpPWpGaD
Lansoprazole—CYP1A1—PPARA activates gene expression—MED12—uterine fibroid	0.00546	0.00997	CbGpPWpGaD
Lansoprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—uterine fibroid	0.00535	0.00976	CbGpPWpGaD
Lansoprazole—CYP3A4—female reproductive system—uterine fibroid	0.00524	0.0116	CbGeAlD
Lansoprazole—CYP1B1—Biological oxidations—CYP17A1—uterine fibroid	0.00519	0.00948	CbGpPWpGaD
Lansoprazole—CYP2D6—female reproductive system—uterine fibroid	0.00516	0.0114	CbGeAlD
Lansoprazole—CYP1B1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00512	0.00935	CbGpPWpGaD
Lansoprazole—ABCB1—uterine cervix—uterine fibroid	0.00495	0.0109	CbGeAlD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00493	0.00899	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.00485	0.00886	CbGpPWpGaD
Lansoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00473	0.00864	CbGpPWpGaD
Lansoprazole—ABCB1—decidua—uterine fibroid	0.00472	0.0104	CbGeAlD
Lansoprazole—CYP2D6—female gonad—uterine fibroid	0.00469	0.0104	CbGeAlD
Lansoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00467	0.00853	CbGpPWpGaD
Lansoprazole—ABCB1—urethra—uterine fibroid	0.00455	0.0101	CbGeAlD
Lansoprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00453	0.00827	CbGpPWpGaD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00449	0.0082	CbGpPWpGaD
Lansoprazole—ABCB1—endometrium—uterine fibroid	0.00448	0.0099	CbGeAlD
Lansoprazole—ABCB1—mammalian vulva—uterine fibroid	0.00433	0.00958	CbGeAlD
Lansoprazole—ABCB1—uterus—uterine fibroid	0.00413	0.00912	CbGeAlD
Lansoprazole—CYP4A11—Metabolism—HPSE2—uterine fibroid	0.00384	0.00702	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00384	0.00701	CbGpPWpGaD
Lansoprazole—ABCB1—female reproductive system—uterine fibroid	0.00371	0.0082	CbGeAlD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.0037	0.00675	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—uterine fibroid	0.00368	0.00672	CbGpPWpGaD
Lansoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00365	0.00667	CbGpPWpGaD
Lansoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00361	0.00658	CbGpPWpGaD
Lansoprazole—ABCB1—female gonad—uterine fibroid	0.00337	0.00746	CbGeAlD
Lansoprazole—CYP2C18—Metabolism—HPSE2—uterine fibroid	0.00336	0.00613	CbGpPWpGaD
Lansoprazole—ABCB1—vagina—uterine fibroid	0.00335	0.00742	CbGeAlD
Lansoprazole—CYP1A1—Biological oxidations—CYP17A1—uterine fibroid	0.0032	0.00584	CbGpPWpGaD
Lansoprazole—CYP1A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00315	0.00576	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.0031	0.00565	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00309	0.00565	CbGpPWpGaD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00296	0.00541	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	0.00293	0.00535	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00289	0.00528	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—CYP17A1—uterine fibroid	0.00262	0.00478	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00258	0.00471	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—HPSE2—uterine fibroid	0.00248	0.00452	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—CYP17A1—uterine fibroid	0.00241	0.00439	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—CYP17A1—uterine fibroid	0.00239	0.00436	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.00238	0.00435	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00237	0.00433	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00235	0.0043	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—HPSE2—uterine fibroid	0.00225	0.00411	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—CYP17A1—uterine fibroid	0.00204	0.00372	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00201	0.00367	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00199	0.00364	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—MED12—uterine fibroid	0.00165	0.00301	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.00157	0.00287	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00155	0.00283	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HPSE2—uterine fibroid	0.00153	0.00279	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.00147	0.00268	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—MED12—uterine fibroid	0.00144	0.00263	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HPSE2—uterine fibroid	0.0014	0.00255	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP17A1—uterine fibroid	0.00138	0.00252	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.00134	0.00246	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HPSE2—uterine fibroid	0.00125	0.00228	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00124	0.00227	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00123	0.00224	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HPSE2—uterine fibroid	0.00122	0.00222	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP17A1—uterine fibroid	0.0012	0.0022	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.0012	0.00219	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HPSE2—uterine fibroid	0.00115	0.0021	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HPSE2—uterine fibroid	0.00114	0.00208	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00113	0.00206	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.00109	0.002	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MED12—uterine fibroid	0.00106	0.00194	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.001	0.00183	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HPSE2—uterine fibroid	0.000973	0.00178	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MED12—uterine fibroid	0.000965	0.00176	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000935	0.00171	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000916	0.00167	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP17A1—uterine fibroid	0.000888	0.00162	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP17A1—uterine fibroid	0.000808	0.00147	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000783	0.00143	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000751	0.00137	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MED12—uterine fibroid	0.000653	0.00119	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MED12—uterine fibroid	0.000599	0.00109	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP17A1—uterine fibroid	0.000547	0.000998	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MED12—uterine fibroid	0.000535	0.000976	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MED12—uterine fibroid	0.000522	0.000953	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP17A1—uterine fibroid	0.000501	0.000915	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MED12—uterine fibroid	0.000492	0.000898	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MED12—uterine fibroid	0.000487	0.00089	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP17A1—uterine fibroid	0.000447	0.000817	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP17A1—uterine fibroid	0.000437	0.000797	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MED12—uterine fibroid	0.000417	0.00076	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP17A1—uterine fibroid	0.000412	0.000751	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP17A1—uterine fibroid	0.000408	0.000745	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP17A1—uterine fibroid	0.000349	0.000637	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MED12—uterine fibroid	0.000321	0.000587	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP17A1—uterine fibroid	0.000269	0.000491	CbGpPWpGaD
